(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid

We are (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid CAS:1012341-50-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
CAS.NO:   1012341-50-2
Synonyms:tert-butyl 2-(methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate
2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylicacidtert-butylester

Molecular Formula: C23H29NO4
Molecular Weight:  383.48100

Physical and Chemical Properties:
Density:1.1±0.1 g/cm3
Boiling point:582.6±50.0 °C at 760 mmHg
Melting point: /
Flash point: 306.2±30.1 °C
Refractive index: 1.546

Specification:
Appearance: White or off-white powder
Purity: >98%
Single impurity: 0.5%max

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Application:Intermediates of Sacubitril CAS:1038924-61-6.

(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid


Related News: In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.4,4,5,5-tetramethyl-2-(3-(triphenylen-2-yl)phenyl)-1,3,2-dioxaborolane CAS:1115639-92-3 Any drug or medication is composed of two components.2-Bromovaleric acid Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.Bis[3-(Triethoxysilyl)Propyl]Tetrasulfide Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.

Related Products
Product Name
2-methoxy-3-nitropyridine View Details
3-bromo-2-fluorobenzaldehyde View Details
1,2-DIIODOETHANE View Details
1-isothiocyanato-4-methoxybenzene manufacturer 1-Bromo-3-fluoro-4-iodobenzene manufacturer Antioxidant 697 manufacturer Antide manufacturer (2R)-2-Hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide manufacturer